Which is the Best Screening Strategy for COPD among Smokers in Primary Care?

References

• Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009; 374(9691):721–732.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soriano JB, García-Río F, Muñoz L, Duran-Tauleria E, Sanchez G, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64(10):863–868.
   PubMed Web of Science ®Google Scholar
• Martinez CH, Mannino DM, Jaimes FA, Curtis JL, Han MK, Hansel NN, Diaz AA. Undiagnosed obstructive lung disease in the united states. Associated factors and long-term mortality. Ann Am Thorac Soc 2015; 12(12):1788–1795.
   PubMedGoogle Scholar
• Llordés M, Jaén A, Almagro P, Heredia JL, Morera J, Soriano JB, et al. Prevalence, risk factors and diagnostic accuracy of COPD among smokers in primary care. COPD 2015; 12(4):404–412.
   PubMedGoogle Scholar
• Jing J, Huang T, Cui W, Xu F, Shen H. Should FEV1/FEV6 replace FEV1/FVC ratio to detect airway obstruction? A metaanalysis. Chest 2009; 135(4):991–998.
   PubMed Web of Science ®Google Scholar
• Kaufmann M, Hartl S, Geyer K, Breyer MK, Burghuber OC. Measuring FEV (6) for detecting early airway obstruction in the primary care setting. Quality and utility of the new PiKo-6 device. Respir Int Rev Thorac Dis 2009; 78(2):161–167.
   Google Scholar
• Represas Represas C, Botana Rial M, Leiro Fernández V, González Silva AI, del Campo Pérez V, Fernández-Villar A. Validación del dispositivo portátil COPD-6 para la detección de patologías obstructivas de la vía aérea. Arch Bronconeumol 2010; 46(8):426–432.
   PubMed Web of Science ®Google Scholar
• Price DB, Tinkelman DG, Halbert RJ, Nordyke RJ, Isonaka S, Nonikov D, et al. Symptom-based questionnaire for identifying COPD in smokers. Respir Int Rev Thorac Dis 2006; 73(3):285–295.
   Google Scholar
• Martinez FJ, Raczek AE, Seifer FD, Conoscenti CS, Curtice TG, D'Eletto T, et al. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD 2008; 5(2):85–95.
   PubMedGoogle Scholar
• Miravitlles M, Llor C, Calvo E, Diaz S, Díaz-Cuervo H, Gonzalez-Rojas N. Validation of the Spanish version of the Chronic Obstructive Pulmonary Disease-Population Screener (COPD-PS). Its usefulness and that of FEV1/FEV6; for the diagnosis of COPD. Med Clin (Barc) 2012; 139(12):522–530.
   PubMed Web of Science ®Google Scholar
• Kögler H, Metzdorf N, Glaab T, Welte T. Preselection of patients at risk for COPD by two simple screening questions. Respir Med 2010; 104(7):1012–1019.
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26:319–338.
   PubMed Web of Science ®Google Scholar
• Roca J, Sanchis J, Agusti-Vidal A, Segarra F, Navajas D, Rodriguez R, et al. Spirometric reference values from Mediterranean population. Bull Eur Physiopathol Respir 1986; 22:217–224.
   PubMedGoogle Scholar
• Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W. Obstructive and restrictive spirometric patterns: fixed cut offs for FEV1/FEV6 and FEV6. Eur Respir J 2006; 27(2):378–383.
   PubMed Web of Science ®Google Scholar
• Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008; 63(5):402–407.
   PubMed Web of Science ®Google Scholar
• Yawn B, Mannino D, Littlejohn T, Ruoff G, Emmett A, Raphiou I, et al. Prevalence of COPD among symptomatic patients in a primary care setting. Curr Med Res Opin 2009; 25(11):2671–2677.
   PubMed Web of Science ®Google Scholar
• Decramer M, Miravitlles M, Price D, Román-Rodríguez M, Llor C, Welte T, et al. New horizons in early stage COPD—improving knowledge, detection and treatment. Respir Med 2011; 105:1576–1587.
   PubMed Web of Science ®Google Scholar
• Jones RCM, Price D, Ryan D, Sims EJ, von Ziegenweidt J, Mascarenhas L, et al. Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. Lancet Respir Med 2014; 2(4):267–276.
   PubMed Web of Science ®Google Scholar
• Fernández-Villar A, López-Campos JL, Represas Represas C, Marín Barrera L, Leiro Fernández V, López Ramírez C, et al. Factors associated with inadequate diagnosis of COPD: on-sint cohort analysis. Int J Chron Obstruct Pulmon Dis 2015; 10:961–967.
   PubMed Web of Science ®Google Scholar
• Barrecheguren M, Monteagudo M, Ferrer J, Borrell E, Llor C, Esquinas C, Miravitlles M. Treatment patterns in COPD patients newly diagnosed in primary cae. A population-based study. Respir Med 2016; 111:47–53.
   PubMed Web of Science ®Google Scholar
• Márquez-Martín E, Soriano JB, Rubio MC, Lopez-Campos JL. 3E project. Differences in the use of spirometry between rural and urban primary care centers in Spain. Int J Chron Obstruct Pulmon Dis 2015; 10:1633–1639.
   PubMed Web of Science ®Google Scholar
• Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB. U.S. Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2008; 148(7):535–543.
   PubMed Web of Science ®Google Scholar
• Bergna MA, García GR, Alchapar R, Altieri H, Casas JCF, Larrateguy L, Nannini LJ, Pascansky D, Grabre P, Zabert G, Miravitlles M. Development of a simple binary response questionnaire to identify airflow obstruction in a smoking population in Argentina. Eur Respir Rev 2015; 24:320–326.
   PubMedGoogle Scholar
• Kotz D, Nelemans P, van Schayck CP, Wesseling GJ. External validation of a COPD diagnostic questionnaire. Eur Respir J 2008; 31(2):298–303.
   PubMed Web of Science ®Google Scholar
• Frith P, Crockett A, Beilby J, Marshall D, Attewell R, Ratnanesan A, et al. Simplified COPD screening: validation of the PiKo-6® in primary care. Prim Care Respir J 2011; 20(2):190–198.
   PubMedGoogle Scholar
• Sichletidis L, Spyratos D, Papaioannou M, Chloros D, Tsiotsios A, Tsagaraki V, et al. A combination of the IPAG questionnaire and PiKo-6® flow meter is a valuable screening tool for COPD in the primary care setting. Prim Care Respir J 2011; 20(2):184–189.
   PubMedGoogle Scholar
• Han MK, Steenrod AW, Bacci ED, Leidy NK, Mannino DM, Thomashow BM, et al. Identifying patients with undiagnosed COPD in primary care settings: insight from screening tools and epidemiologic studies. Chronic Obstr Pulm Dis Miami Fla 2015; 2(2):103–121.
   PubMedGoogle Scholar
• Zhou Y-M, Chen S-Y, Tian J, Cui J-Y, Li X-C, Hong W, et al. Development and validation of a chronic obstructive pulmonary disease screening questionnaire in China. Int J Tuberc Lung Dis 2013; 17(12):1645–1651.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Fernández I, Guerrero T, Murio C. The development and efficacy of a primary care screening program for chronic obstructive pulmonary disease. The PADOC project. Arch Bronconeumol 2000; 36:500–505.
   PubMedGoogle Scholar
• Nelson SB, LaVange LM, Nie Y, Walsh JW, Enright PL, Martinez FJ, et al. Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population. Chest 2012; 142(2):358–366.
   PubMed Web of Science ®Google Scholar
• Swanney MP, Jensen RL, Crichton DA, Beckert LE, Cardno LA, Crapo RO. FEV (6) is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med 2000; 162(3 Pt 1):917–919.
   PubMed Web of Science ®Google Scholar
• Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W. FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest 2005; 127(5):1560–1564.
   PubMed Web of Science ®Google Scholar
• Lamprecht B, Schirnhofer L, Tiefenbacher F, Kaiser B, Buist SA, Studnicka M, et al. Six-second spirometry for detection of airway obstruction: a population-based study in Austria. Am J Respir Crit Care Med 2007; 176(5):460–464.
   PubMed Web of Science ®Google Scholar
• Gleeson S, Mitchell B, Pasquarella C, Reardon E, Falsone J, Berman L. Comparison of FEV6 and FVC for detection of airway obstruction in a community hospital pulmonary function laboratory. Respir Med 2006; 100(8):1397–1401.
   PubMed Web of Science ®Google Scholar
• Rosa FW, Perez-Padilla R, Camelier A, Nascimento O, Menezes AM, Jardim JR. Efficacy of the FEV1/FEV6 ratio compared to the FEV1/FVC ratio for the diagnosis of airway obstruction in subjects aged 40 years or over. Braz J Med Biol Res 2007; 40:1615–1621.
   PubMed Web of Science ®Google Scholar
• Haroon S, Jordan R, Takwoingi Y, Adab P. Diagnostic accuracy of screening tests for COPD: a systematic review and meta-analysis. BMJ Open 2015; 5(10):e008133.
   PubMed Web of Science ®Google Scholar
• Mohamed Hoesein FAA, Zanen P, Sachs APE, Verheij TJM, Lammers JWJ, Broekhuizen BDL. Spirometric thresholds for diagnosing COPD: 0.70 or LLN, pre- or post-bronchodilator values? COPD 2012; 8:338–343.
   Google Scholar